Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 106 results for "international society of pharmacovigi..."

Pharmacovigilance Meet Sounds Alarm Over Drug Misuse and Side-Effects
MedIndia

Pharmacovigilance meet sounds alarm over drug misuse

The three-day international convention of International Society of Pharmacovigilance (ISOP), which ended here on Wednesday, has painted an alarming scenario of drug misuse and its generally ignored side-effects on patients.The convention, attended by over 200 ... Prokerala, 1 month ago
[x]  

Selfregulation Code of Conduct for the Epharmacy Sector in the Interest of Consumer

E-pharmacy model provides digital tracking and traceability of medicines , addresses the ... Category Business/ FinanceBusiness Services Location India Business Wire India E-pharmacy model provides digital tracking and traceability of ...
 Pharma Focus Asia2 weeks ago Self-regulation Code of Conduct for the E-pharmacy Sector in the Interest of Consumer  Businessworld India2 weeks ago
[x]  
PharmaVOICE

Alexion Release: New Data From ALXN1210 Dose-Escalation Study Presented At American Society of Hematology Show Rapid And Sustained Reductions In LDH In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NEW HAVEN, Conn.--( BUSINESS WIRE )--Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) announced today that new data from an ongoing Phase 1/2 dose-escalation study of ALXN1210 in patients with paroxysmal nocturnal hemoglobinuria (PNH) showed rapid and ...
 BioSpace19 hours ago Alexion Pharmaceuticals : New Data from ALXN1210 Dose-Escalation Study Presented at ASH Show Rapid and Sustained Reductions in LDH in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)  4 Traders2 days ago New Data from ALXN1210 Dose-Escalation Study Presented at ASH Show Rapid and Sustained Reductions in LDH in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)  Financial Buzz1 day ago Alexion Reports Third Quarter 2016 Results  PharmaVOICE1 month ago
[x]  

Workshop: measuring the impact of pharmacovigilance activities

/PRNewswire Policy/ The event will be web-streamed on 5-6 December The European Medicines Agency (EMA) is organising a workshop to discuss methods to measure the impact of pharmacovigilance activities on patient safety. The event will be ...
 Pharmacy Choice3 days ago News and press releases: Workshop: measuring the impact of pharmacovigilance activities  European Medicines Agency1 week ago
Yahoo! Finance

InMed shows CBD affects protein in lung healing

Dr. Sazzad Hossain reports INMED ANNOUNCES PROGRESS ON COPD PROGRAM InMed Pharmaceuticals Inc. is providing an update on its research and development program in the use of cannabinoids for the treatment of chronic obstructive pulmonary disease ...
 Stockwatch5 hours ago InMed Pharmaceuticals, Inc. (IMLFF: OTCQB) | InMed announces progress on COPD program  OTC Markets7 hours ago InMed announces progress on COPD program  4 Traders7 hours ago
[x]  

Ipsen Biopharmaceuticals, Inc. Announces Data Presentations at the 2016 Annual Meeting of the Child Neurology Society

BASKING RIDGE, N.J. , Oct. 26, 2016 /PRNewswire/ -- Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY) (Ipsen), today announced that three abstracts were chosen for poster presentations during the annual meeting of the ...
 Barchart1 month ago
[x]  

Biosimilars and Follow-on Biologics: A Pharmacist Opportunity »

Pharmacists need to be experts on follow-on biologics (FOBs), including biosimilars, so they can provide education to health professionals about safe prescribing and use, which ultimately affects patient care. Seamless interchangeability among ...
 Pharmacy Times2 weeks ago

From regulator to pharma industry specialist

Profiles Published on November 16th, 2016 | by Dr. Thomas Lönngren, former head of the EMA and today a pharmaceutical consultant, provides some insights on the aftermath of Brexit, describes current challenges the industry is facing and takes ...
 Nordic Life Science2 weeks ago

Opportunities and Challenges for Drug Development: PublicPrivate Partnerships, Adaptive Designs and Big Data

Background In 2002 about 50% of all prescriptions in the U.S. were filled with generics; this has increased to 88% in 2014 ( Munos, 2016 ). Nevertheless, generics accounted for only 17% of total drug expenditure in 2014. In other words, the ...
 Frontiers in Neurorobotics12 hours ago

Portuguese dermatologists position o...

In February 2016 the Portuguese National Authority of Medicines and Health Products (INFARMED, IP) released a recommendation document about the use of biosimilars. Based on these recommendations, dermatologists from the Portuguese College of ...
 GaBi Online5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less